Since CuII(atsm) is known to increase SOD1 copper content in animal models of ALS (Roberts et al., 2014), we hypothesize that the antioxidant reactions raised by CuII(atsm) may contribute to reducing VCAM-1 expression after systemic LPS challenge. The gene discussed is SOD1; the disease is amyotrophic lateral sclerosis.